Professor Irina Vetter
Professor

Irina Vetter

Email: 
Phone: 
+61 7 334 62660

Background

I am an NHMRC Leadership Fellow with joint apointments at the Institute for Molecular Bioscience (IMB) and School of Pharmacy, UQ. My research interests lie in the fields of peripheral pain mechanisms, target identification and analgesic drug discovery. I investigate the contribution of ion channels to sensory neuronal physiology using highly subtype-selective toxins isolated from venomous animals with the aim to develop novel analgesics with improved efficacy and tolerability.

Availability

Professor Irina Vetter is:
Available for supervision
Media expert

Fields of research

Clinical sciences Neurosciences Pharmacology and pharmaceutical sciences

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • Understanding pain pathways

    Pain is a major medical and socio-economic issue affecting one in five Australians. Our research aims to understand the molecular mechanisms behind pain. The current focus of the lab is to use toxins from plants and venomous animals to understand the molecular pharmacology of pain. These toxins are highly selective for ion channels and receptors found in the sensory neurons that detect pain and can potentially be developed into novel analgesics. Our research also investigates the mechanisms contributing to chemotherapy-induced pain, cancer-associated pain, inflammatory and neuropathic pain, and the painful marine toxin disease known as ciguatera. To investigate the neuropharmacology of pain we use a range of techniques including: in vivo pain pathway characterisation, high-content imaging of cultured sensory neurons, high-throughput screening using calcium and membrane potential assays, and traditional pharmacological assays. While all pain has similar symptoms, it is becoming clear that the underlying mechanisms behind pain can vary. Our research has already challenged traditional understanding of pain pathways and sensory neuronal physiology. We work in collaboration with other leading Australian and international researchers to identify novel therapeutic pain pathways and targets. By uncovering these new pain pathways, as well as identifying novel targets on peripheral sensory neurons, we aim to develop more effective pain therapies that treat the underlying cause of the pain, not just the symptoms.

Search Professor Irina Vetter’s works on UQ eSpace

249 works between 2004 and 2024
All (249) Journal Article (196) Book Chapter (13) Conference Publication (39) Other Outputs (1)

221 - 240 of 249 works

2011

Book Chapter

Natural product ligands of TRP channels

Vetter, Irina and Lewis, Richard J. (2011). Natural product ligands of TRP channels. Transient receptor potential channels. (pp. 41-85) edited by Md. Shahidul Islam. New York, United States: Springer. doi: 10.1007/978-94-007-0265-3_3

Natural product ligands of TRP channels

2011

Conference Publication

Conotoxins - blueprints for GPCR drug discovery?

Muttenthaler, M., Gruber, C. W., Andersson, A., Vetter, I., Nevin, S. T., Grishin, A. A., Dutertre, S., Daly, N. L., Craik, D. J., Adams, D. J., Lewis, R. J. and Alewood, P. F. (2011). Conotoxins - blueprints for GPCR drug discovery?. 22nd American Peptide Symposium, San Diego, CA, United States, 25-30 June 2011. Hoboken, NJ, United States: John Wiley & Sons.

Conotoxins - blueprints for GPCR drug discovery?

2011

Conference Publication

Expression of the G Protein-Coupled Receptor 68 is Increased by TNF-Mediated Inflammatory Signalling

DE Valliere, C, Hiller, C, Kellermeier, S, Crucet, M, Vetter, I, Inserra, M, Lewis, RJ, Cooper, MA, Vidal, S, Seuwen, K, Wagner, CA, Fried, M, Kullak-Ublick, GA, Rogler, G and Eloranta, JJ (2011). Expression of the G Protein-Coupled Receptor 68 is Increased by TNF-Mediated Inflammatory Signalling. Conference on Digestive Disease Week 2011, Chicago Il, May 07-10, 2011. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Expression of the G Protein-Coupled Receptor 68 is Increased by TNF-Mediated Inflammatory Signalling

2011

Conference Publication

Expression of Proton-Sensing G Protein-Coupled Receptor 68 (ogr1) Is Increased by Tnf-Mediated Inflammatory Signalling

De Valliere, C., Hiller, C., Kellermeier, S., Vetter, I., Inserra, M., Lewis, R.J., Cooper, M.A., Vidal, S., Seuwen, K., Wagner, C.A., Fried, M., Kullak-Ublick, G.A., Rogler, G. and Eloranta, J.J. (2011). Expression of Proton-Sensing G Protein-Coupled Receptor 68 (ogr1) Is Increased by Tnf-Mediated Inflammatory Signalling. 2011 Joint Annual Meeting of the German, Swiss, and Austrian Societies for Clinical Pharmacology and Toxicology, Zurich, Switzerland, 20-22 October 2011. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Expression of Proton-Sensing G Protein-Coupled Receptor 68 (ogr1) Is Increased by Tnf-Mediated Inflammatory Signalling

2011

Journal Article

Venomics: A new paradigm for natural products-based drug discovery

Vetter, Irina, Davis, Jasmine L., Rash, Lachlan D., Anangi, Raveendra, Mobli, Mehdi, Alewood, Paul F., Lewis, Richard J. and King, Glenn F. (2011). Venomics: A new paradigm for natural products-based drug discovery. Amino Acids, 40 (1), 15-28. doi: 10.1007/s00726-010-0516-4

Venomics: A new paradigm for natural products-based drug discovery

2011

Conference Publication

Accelerated biodiscovery of ion channel modulators

Vetter, Irina and Lewis, Richard J. (2011). Accelerated biodiscovery of ion channel modulators. 84th Annual Meeting of the Japanese Pharmacological Society/11th Southeast Asian Western Pacific Regional Meeting of Pharmacologists, Yokohama, Japan, 22-24 March 2011. Kyoto, Japan: Nihon Yakuri Gakkai Henshuubu.

Accelerated biodiscovery of ion channel modulators

2010

Journal Article

Golgi calcium pump secretory Pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231

Grice, Desma M., Vetter, Irina, Faddy, Helen M., Kenny, Paraic A., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2010). Golgi calcium pump secretory Pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. Journal of Biological Chemistry, 285 (48), 37458-37466. doi: 10.1074/jbc.M110.163329

Golgi calcium pump secretory Pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231

2010

Journal Article

Chemical synthesis and structure of the prokineticin Bv8

Morales, Rodrigo A. V., Daly, Norelle L., Vetter, Irina, Mobli, Mehdi, Napier, Ian A., Craik, David J., Lewis, Richard J., Christie, MacDonald J., King, Glenn F., Alewood, Paul F. and Durek, Thomas (2010). Chemical synthesis and structure of the prokineticin Bv8. ChemBioChem, 11 (13), 1882-1888. doi: 10.1002/cbic.201000330

Chemical synthesis and structure of the prokineticin Bv8

2010

Journal Article

The response of dorsal root ganglion axons to nerve growth factor gradients depends on spinal level

Vetter, I, Pujic, Z and Goodhill, GJ (2010). The response of dorsal root ganglion axons to nerve growth factor gradients depends on spinal level. Journal of Neurotrauma, 27 (8), 1379-1386. doi: 10.1089/neu.2010.1279

The response of dorsal root ganglion axons to nerve growth factor gradients depends on spinal level

2010

Journal Article

Characterization of endogenous calcium responses in neuronal cell lines

Vetter, Irina and Lewis, Richard J. (2010). Characterization of endogenous calcium responses in neuronal cell lines. Biochemical Pharmacology, 79 (6), 908-920. doi: 10.1016/j.bcp.2009.10.020

Characterization of endogenous calcium responses in neuronal cell lines

2010

Journal Article

Axon guidance by growth-rate modulation

Mortimer, D., Pujic, Z., Vaughan, T., Thompson, A. W., Feldner, J., Vetter, I. and Goodhill, G. J. (2010). Axon guidance by growth-rate modulation. Proceedings of the National Academy of Sciences of the United States of America, 107 (11), 5202-5207. doi: 10.1073/pnas.0909254107

Axon guidance by growth-rate modulation

2010

Conference Publication

Consequences of siRNA-mediated inhibition of the secretory pathway calcium ATPase 1 in human breast cancer cell line

Grice, Desma, Vetter, Irina, Faddy, Helen, Paraic, Kenny A, Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2010). Consequences of siRNA-mediated inhibition of the secretory pathway calcium ATPase 1 in human breast cancer cell line. New Horizons in Calcium Signaling, Beijiing, China, October 10-13 2010.

Consequences of siRNA-mediated inhibition of the secretory pathway calcium ATPase 1 in human breast cancer cell line

2010

Conference Publication

Oxytocin agonist design - A selenocysteine mimetic reveals a functional selectivity switch for the human oxytocin receptor

Muttenthaler, M. M., de Araujo, A. D., Andersson, A., Vetter, I., Gruber, C., Ramos, Y. Garcia, Feytens, D., Bergmayr, C., Freissmuth, M., Lewis, R. and Alewood, P. (2010). Oxytocin agonist design - A selenocysteine mimetic reveals a functional selectivity switch for the human oxytocin receptor. 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010. Chichester, West Sussex, U.K.: John Wiley & Sons. doi: 10.1002/psc.1303

Oxytocin agonist design - A selenocysteine mimetic reveals a functional selectivity switch for the human oxytocin receptor

2010

Conference Publication

The golgi-localised calcium atpase in breast cancer

Grice, Desma, Vetter, Irina, Faddy, Helen, Kenny, P.A, Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2010). The golgi-localised calcium atpase in breast cancer. OzBio 2010 - The Molecules of Life - from Discovery to Biotechnology, Melbourne, 26th September to 1st October 2010.

The golgi-localised calcium atpase in breast cancer

2009

Journal Article

A Bayesian model predicts the response of axons to molecular gradients

Mortimer, Duncan, Feldner, Julia, Vaughan, Timothy, Vetter, Irina, Pujic, Zac, Rosoff, William J., Burrage, Kevin, Dayan, Peter, Richards, Linda J. and Goodhill, Geoffrey J. (2009). A Bayesian model predicts the response of axons to molecular gradients. Proceedings of the National Academy of Sciences of the United States of America, 106 (25), 10296-10301. doi: 10.1073/pnas.0900715106

A Bayesian model predicts the response of axons to molecular gradients

2008

Journal Article

Rapid, Opiod-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization

Vetter, Irina, Cheung, Wei, Peiris, Madusha, Wyse, Bruce D., Roberts-Thomson, Sarah J., Zheng, Jie, Monteith, Gregory R. and Cabot, Peter J (2008). Rapid, Opiod-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization. Journal of Biological Chemistry, 283 (28), 19540-19550. doi: 10.1074/jbc.M707865200

Rapid, Opiod-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization

2008

Journal Article

Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol

Vetter, Irina, Wyse, Bruce D., Roberts-Thomson, Sarah J., Monteith, Gregory R. and Cabot, Peter J. (2008). Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol. European Journal of Pain, 12 (4), 441-454. doi: 10.1016/j.ejpain.2007.07.001

Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol

2007

Other Outputs

Mechanisms involved in functional interactions between the Transient Receptor Potential Vanilloid 1 and μ opioid receptor

Vetter, Irina (2007). Mechanisms involved in functional interactions between the Transient Receptor Potential Vanilloid 1 and μ opioid receptor. PhD Thesis, School of Pharmacy, The University of Queensland. doi: 10.14264/158764

Mechanisms involved in functional interactions between the Transient Receptor Potential Vanilloid 1 and μ opioid receptor

2006

Journal Article

The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway

Vetter, Irina, Wyse, Bruce D., Monteith, Gregory R., Roberts-Thomson, Sarah J. and Cabot, Peter J. (2006). The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway. Molecular Pain, 2 (22) 22, 1-16. doi: 10.1186/1744-8069-2-22

The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway

2006

Journal Article

The Effects of pH on Beta-Endorphin and Morphine Inhibition of Calcium Transients in Dorsal Root Ganglion Neurons

Vetter, I., Kapitzke, D., Hermanussen, S., Monteith, G. R. and Cabot, P. J. (2006). The Effects of pH on Beta-Endorphin and Morphine Inhibition of Calcium Transients in Dorsal Root Ganglion Neurons. The Journal of Pain, 7 (7), 488-499. doi: 10.1016/j.jpain.2006.01.456

The Effects of pH on Beta-Endorphin and Morphine Inhibition of Calcium Transients in Dorsal Root Ganglion Neurons

Current funding

  • 2024 - 2027
    Defining a new family of sodium channel accessory proteins
    ARC Discovery Projects
    Open grant
  • 2024 - 2028
    DISCERN - Disciplinary Integration to Solve the Enigma of Chronic Pain: Evaluating Personalised Care and its Impact with Innovative Clinical Trials and Research in Neurobiology, Psychology and Society
    NHMRC Synergy Grants
    Open grant
  • 2023 - 2025
    Studying the basis of and developing new therapies to treat heart disease
    IPF Healthy - Medical Research
    Open grant
  • 2023 - 2026
    Tuning the activating stimulus of voltage-gated sodium channels
    ARC Discovery Projects
    Open grant
  • 2023 - 2027
    Mechanistic and pharmacological insights into peripheral sensory neuron function in physiological and pathological pain
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2024 - 2025
    Super-resolution platform to accelerate biological and molecular research
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2024 - 2025
    IL-1RAP: novel target for chemotherapy-induced neuropathy
    Cantargia AB
    Open grant
  • 2022 - 2024
    A humanised sensory neuron high-throughput screening platform
    ARC Linkage Projects
    Open grant
  • 2022 - 2024
    Reducing long-term side-effects of chemotherapy in cancer survivors
    The Kid's Cancer Project
    Open grant
  • 2021 - 2023
    Bivalent analgesics: rational design of selective ion channel inhibitors with optimised mechanism of action
    NHMRC IDEAS Grants
    Open grant
  • 2020
    Electrophysiology Platform for Ion-channel Characterisation
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2020
    New VAST frontiers in non-opioid pain therapies
    VAST Biosciences Pty Ltd
    Open grant
  • 2020 - 2021
    An integrated, multi-node bio-layer interferometry facility
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2020 - 2023
    Mechanism-based treatments for chemotherapy-induced pain
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2022
    Toxins from Down Under: Novel tools to understand and modulate ion channels
    ARC Discovery Projects
    Open grant
  • 2019 - 2021
    Developing treatments for vincristine-induced neuropathy
    The Kid's Cancer Project
    Open grant
  • 2019 - 2022
    Gain from pain: new tools from venomous animals for exploring pain pathways
    ARC Discovery Projects
    Open grant
  • 2019
    Chemical Purification Network
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019
    In vivo imaging system for tracking inflammation, infection, cancer, pain and bioactive molecules
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019 - 2022
    The role of ion channels in pain pathways
    NHMRC Career Development Fellowship
    Open grant
  • 2019
    Vevo 3100 Imaging System for ultrahigh resolution and frame rate echocardiographic assessment of small animals.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2019
    Coagulotoxic effects of Brazilian snake venoms: Role in adaptive evolution and human pathophysiological implications
    UQ-FAPESP Strategic Research Fund SPRINT
    Open grant
  • 2018
    High-throughput ion channel pharmacology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018
    Multichannel peptide synthesiser to accelerate UQ's biodiscovery pipeline and peptide drug development programs
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2020
    Novel non-opioid analgesics
    NHMRC Development Grant
    Open grant
  • 2018 - 2020
    Silencing visceral nociceptors by targeting NaV1.1: A novel therapeutic approach for treating Irritable Bowel Syndrome (NHMRC Project Grant led by The Flinders University of South Australia)
    Flinders University
    Open grant
  • 2017 - 2024
    ACRF Cancer Ultrastructure and Function Facility
    Australian Cancer Research Foundation
    Open grant
  • 2017 - 2019
    Novel analgesic approaches: harnessing functional interactions between sodium channels and opioids
    NHMRC Project Grant
    Open grant
  • 2016 - 2018
    The role of Nav1.6 in peripheral pain pathways
    International Association for the Study of Pain
    Open grant
  • 2016
    4D Mass Spectrometer
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2018
    A pharmacological approach to define the contribution of Nav1.7 to pain pathways
    NHMRC Project Grant
    Open grant
  • 2016
    Establishing a High-Throughput, Microwave-Assisted Automated Peptide Synthesis Facility at PACE
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Integrative blood coagulation research core facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Patch-clamp electrophysiology platform for drug and insecticide discovery
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    Murine behavioural phenotyping facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    Protein Analysis Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    The assessment of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells to identify and characterize new therapeutic targets for diseases
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2016
    TRPC5 in teeth - a novel target for tooth pain treatment
    Go8 Australia - Germany Joint Research Co-operation Scheme
    Open grant
  • 2014 - 2018
    Using toxins to understand the mechanisms of pain
    ARC Future Fellowships
    Open grant
  • 2014
    A medium-throughput cell isolation and analysis suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2017
    A VAST potential for ion channel drug discovery
    ARC Linkage Projects
    Open grant
  • 2013 - 2018
    Efficacy Profiling Innovation in Novel Pain Therapeutics Discovery
    ARC Linkage Projects
    Open grant
  • 2013 - 2016
    The role of sodium channels in pain and cold allodynia
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Understanding the fundamental molecular basis of sensory perception
    Ramaciotti Foundation
    Open grant
  • 2012 - 2013
    High throughput identification of novel analgesic peptides from cone snail and spider venom
    Queensland Pharmacy Research Trust
    Open grant
  • 2012
    Structure-activity relationship of the novel uO-conotoxin MfVIA
    UQ Early Career Researcher
    Open grant
  • 2012 - 2013
    The pharmacology and molecular mechanisms of ciguatoxin-induced cold allodynia
    Cancer Council Queensland
    Open grant
  • 2011 - 2012
    Development of a mouse model of ciguatoxin-induced cold allodymia to dissect the underlying mechanisms of cold pain
    IASP Early Career Research Grant
    Open grant
  • 2010 - 2011
    Molecular Targets and Mechanisms involved in ciguatoxin-induced cold allodynia
    Go8 Australia - Germany Joint Research Co-operation Scheme
    Open grant
  • 2010 - 2011
    ResTeach 2010 0.1 FTE School of Pharmacy
    Open grant
  • 2009 - 2013
    NHMRC Training Fellowship: Using conesnail venom to better understand chronic pain
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Availability

Professor Irina Vetter is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Investigating ion channel function and pathology using toxins as tools

    Principal Advisor

    Other advisors: Dr Jennifer Deuis, Dr Angelo Keramidas

  • Doctor Philosophy

    Understanding the function of sodium channel accessory proteins to develop new treatments for chronic pain

    Principal Advisor

    Other advisors: Dr Jennifer Deuis, Professor Mehdi Mobli

  • Doctor Philosophy

    Reducing long-term side-effects of chemotherapy in cancer survivors

    Principal Advisor

    Other advisors: Dr Ingrid Winkler, Dr Hana Starobova

  • Doctor Philosophy

    Structure and function of ion channels in pain pathways: a toxin perspective

    Principal Advisor

    Other advisors: Dr Jennifer Deuis

  • Master Philosophy

    Neuro-immune mechanisms of peripheral neuropathy: a novel target offering new prevention and treatment strategies

    Principal Advisor

    Other advisors: Dr Hana Starobova

  • Master Philosophy

    Using peptide toxins to understand the nociceptor signallosome

    Principal Advisor

    Other advisors: Dr Jennifer Deuis

  • Doctor Philosophy

    Developing Models of Cancer Therapy-Induced Late Effects

    Principal Advisor

    Other advisors: Dr Hana Starobova

  • Doctor Philosophy

    Discovery and characterisation of multi-valent peptides

    Principal Advisor

    Other advisors: Professor Mehdi Mobli

  • Doctor Philosophy

    Understanding pain mechanisms in the path towards target-specific analgesic agent design

    Principal Advisor

    Other advisors: Dr Ingrid Winkler, Dr Hana Starobova

  • Doctor Philosophy

    Characterization of bivalency in disulfide-rich peptides

    Principal Advisor

    Other advisors: Professor Mehdi Mobli

  • Doctor Philosophy

    Characterization of novel family of voltage-gated sodium channel toxins from ant venoms

    Associate Advisor

    Other advisors: Dr Sam Robinson

  • Doctor Philosophy

    Accessing structurally elusive states of sodium channels as novel analgesic targets

    Associate Advisor

    Other advisors: Dr Thomas Durek, Professor Mehdi Mobli

  • Doctor Philosophy

    Identification and characterisation of new pain-causing toxins from animal venoms

    Associate Advisor

    Other advisors: Dr Jennifer Deuis, Dr Sam Robinson

  • Doctor Philosophy

    Probing ion channel function using venom peptides

    Associate Advisor

    Other advisors: Dr Angelo Keramidas

  • Doctor Philosophy

    Identification and characterisation of new pain-causing toxins from animal venoms

    Associate Advisor

    Other advisors: Dr Jennifer Deuis, Dr Sam Robinson

  • Doctor Philosophy

    Using genomics to predict the mechanism-of-action of a chemical entity

    Associate Advisor

    Other advisors: Associate Professor Sonia Shah

  • Doctor Philosophy

    Evolutionary shifts in venom function and chemistry within Bees (Hymenoptera: Apiformes)

    Associate Advisor

    Other advisors: Dr Andrew Walker, Dr Sam Robinson

  • Doctor Philosophy

    New Toxin Tools for Dissecting Pain

    Associate Advisor

    Other advisors: Dr Thomas Durek, Dr Sam Robinson

  • Doctor Philosophy

    Using toxins as tools to understand sodium channel structure and function

    Associate Advisor

    Other advisors: Dr Jennifer Deuis

  • Doctor Philosophy

    Chemotherapy-induced motor neuropathy: towards improved understanding of motor neuron dysfunction during chemotherapy

    Associate Advisor

    Other advisors: Dr Hana Starobova

Completed supervision

Enquiries

Contact Professor Irina Vetter directly for media enquiries about:

  • analgesics
  • cancer
  • cancer pain
  • chemotherapy pain
  • chronic pain
  • ciguatera
  • diabetes
  • drug development
  • drug discovery
  • ion channels
  • irritable bowel syndrome
  • neuropathic pain
  • neuropathy
  • neuropharmacology
  • toxins

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au